Elevated expression of ferritin H-chain mRNA in metastatic ovarian tumor

Cancer Investigation

Volumn 14, Issue 6, 1996, Pages 518-526

  Tripathi, Pulak K ^a   Chatterjee, Sunil K ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; FERRITIN H CHAIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; OVARY CARCINOMA; PRIORITY JOURNAL;

EID: 0030445991     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909609076897     Document Type: Article

References (35)

1. Fidler IJ: Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res 50:6130-6138, 1990.
2. Liotta L: Gene products which play a role in cancer invasion and metastasis. Breast Cancer Res Treat 11:113-124, 1988.
3. Hart IR, Goode NT, Wilson RE: Molecular aspects of the metastatic cascade. Biochim Biophys Acta 989:65-84, 1989.
4. Nicolson GL: Tumor cell instability, diversification, and progression to the metastatic phenotype: From oncogene to oncofetal expression. Cancer Res 47:1473-1487, 1987.
5. Fidler IJ, Radinsky R: Genetic control of cancer metastasis. Editorial. J Natl Cancer Inst 82:66-68, 1990.
6. Crickard K, Niedbala MJ, Crickard U, et al: Characterization of human ovarian and endometrial carcinoma cell lines established on extracellular matrix. Gynecol Oncol 32:163-173, 1989.
7. Crickard K, Crickard U, Yoonessi M: Human ovarian carcinoma cells maintained on extracellular matrix versus plastic. Cancer Res 43:2762-2767, 1983.
8. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
9. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, Ed. 2. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989.
10. Gubler U, Hoffman BJ: A simple and very efficient method for generating cDNA libraries. Gene 25:263-269, 1983.
11. Tripathi PK, Chatterjee SK: Simple method for preparing pure lambda phage DNA. Methods Mol Cell Biol 3:232-238, 1992.
12. Vogelstein B, Gillespie D: Preparation and analytical purification of DNA from agarose. Proc Natl Acad Sci USA 76:615-619, 1979.
13. Feinberg AP, Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13, 1983.
14. Altschul SF, Gish W, Miller, W, et al: Basic local alignment search tool. J Mol Biol 215:403-410, 1990.
15. Hagen FS, Gray CL, Kuijper JL: Assaying the quality of cDNA libraries. BioTechniques 6:340-345, 1988.
16. Sarcione EJ, Smalley JR, Lema MJ, et al: Increased ferritin synthesis and release by Hodgkin's disease pripheral blood lymphocytes. Br J Cancer 20:339-346, 1977.
17. Vezzone P, Levi S, Gabri E, et al: Ferritins in malignant and non-malignant lymphoid cells Br J Haematol 62:105-110, 1986.
18. Guner G, Kirkali G, Yenisey C, et al: Cytosol and serum ferritin in breast carcinoma. Cancer Lett 67:103-112, 1992.
19. Vaughn CB, Weinstein R, Bond B, et al: Ferritin content in human cancerous and noncancerous colonie tissue. Cancer Invest 5:7-10, 1987.
20. Weinstein RE, Bond BH, Silberberg BK: Tissue ferritin concentration in carcinoma of the breast. Cancer 50:2406-2409, 1982.
21. Weinstein RE, Bond BH, Silberberg BK, et al: Tissue ferritin concentration and prognosis in carcinoma of the breast. Breast Cancer Res Treat 14:349-353, 1989.
22. Nidbala MJ, Madidyalakan R, Matta K, et al: The role of glycosi-dases in human ovarian carcinoma cell mediated degradation of subendothelial extracellular matrix. Cancer Res 47:4634-4641, 1987.
23. Niedbala MJ, Crickard K, Bernacki RJ: In vitro degradation of extracellular matrix by human ovarian carcinoma cells. Clin Exp Metast 5:181-197, 1987.
24. Hastie ND, Bishop JO: The expression of three abundance classes of messenger RNA in mouse tissues. Cell 9:761-774, 1976.
25. Travis GH, Sutcliffe JG: Phenol emulsion-enhanced DNA-driven subtractive cDNA cloning: Isolation of low-abundance monkey cortex-specific mRNAs. Proc Natl Acad Sci USA 85:1696-1700, 1988.
26. Schweinfest CW, Henderson KW, Gu JR, et al: Subtraction hybridization of cDNA libraries from colon carcinoma and hepatic cancer. Genet Anal Techn Appl 7:64-70, 1990.
27. Boyd D, Vecoli C, Belcher DM, et al: Structural and functional relationships of human ferritin H and L chains deduced from cDNA clones. J Biol Chem 260:11755-11761, 1985.
28. Stierer M, Rosen HR, Forster E, et al: Placental isoferritin (PLF) in comparison with MCA and CEA in advanced breast cancer - First data from a pilot study. Breast Cancer Res Treat 19:283-288, 1991.
29. Cox R, Gyde OH, Leyland MJ: Serum ferritin levels in small cell lung cancer. Eur J Cancer Clin Oncol 22:831-835, 1986.
30. Cunietti E, Locatelli E, Vaiani G, et al: Carcinoembryonic antigen, ferritin, anionic glycoproteins, and their sialic acid content in advanced colorectal cancer. Cancer Detect Prev 8:227-232, 1985.
31. Lugar TA, Linkesch W, Knobler R, et al: Serial determination of serum ferritin levels in patients with malignant melanoma. Oncology 40:263-267, 1983.
32. Ito H, Takagi Y, Ando Y, et al: Serum ferritin levels in patients with cervical cancer. Obstet Gynecol 55:358-362, 1980.
33. Kikyo N, Suda M, Kikyo N, et al: Purification and characterization of a cell growth factor from a human leukemia cell line: Immunological identity with ferritin. Cancer Res 54:268-271, 1994.
34. Rossi MC, Zetter BR: Selective stimulation of prostatic carcinoma cell proliferation by transferrin. Proc Natl Acad Sci USA 89:6197-6201, 1992.
35. Inoue T, Cavanaugh PG, Steck PA, et al: Differences in transferrin response and numbers of transferrin receptors in rat and human mammary carcinoma lines of different metastatic potentials. J Cell Physiol 156:212-217, 1993.